A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the steady-state clearance of nevirapine among
HIV-1 positive patients with hepatic fibrosis, and to examine whether the degree of hepatic
impairment influences clearance.